According to in-Pharma Technologist, the company Stirling Products is in talks with a few large pharma companies about how they can use the High Density Aerosol. This particular method helps increase the delivery of inhalable medications.
According to the article:
An early, single-dose device based on the HDA platform was granted 510k approval by the US Food and Drug Administration (FDA). Later devices use newly patented technologies and capabilities.
No comments:
Post a Comment